DVT News
-
Post-COVID Risk for Blood Clot Lasts at Least 6 Months
New findings suggest COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding.
-
Binge-Watching TV Linked to Higher Blood Clot Risk
People who sit and watch TV at least 4 hours daily had a 35% higher chance of getting potentially fatal blood clots than people who watch TV for 2½ hours or less daily, a new study says.
-
Blood Type Might Raise Odds for Certain Health Conditions
Certain blood types may increase a person's risk of different health problems, a new study suggests.
-
FDA Approves First Generic of Popular Blood Thinner
The FDA approved the first generic versions of the powerful blood thinner Eliquis (apixaban) used to prevent stroke and other conditions.
-
Shorter People May Duck Risk of Varicose Veins
Every additional 4 inches in height increases your risk of varicose veins by about 25 percent, said researcher Dr. Erik Ingelsson, a professor of cardiovascular medicine with Stanford University School of Medicine.
-
More Evidence Too Much Sitting Raises Clot Risk
A new study out of Japan found that people fleeing a natural disaster seemed to be at risk of an unexpected cause of death -- life-threatening blood clots in the legs and lungs triggered by sitting in a car for a long time.
-
Varicose Veins Tied to Higher Odds for Blood Clots
Varicose veins are a common condition affecting about 23 percent of American adults, the researchers said.
-
Too Much TV Could Boost Your Odds for a Blood Clot
The study found that people who spend too much time in front of the TV are at increased risk for blood clots in their veins -- a condition called venous thromboembolism (VTE).
-
Fainting Rarely Tied to Blood Clot, Study Finds
A study of more than 1.6 million adults treated in the emergency department after fainting -- medically known as a "syncope" -- found less than 1 percent had a blockage in an artery leading to the lungs, or pulmonary embolism.
-
Powerful Clot-Busting Drugs Not Useful For DVT
Deep vein thrombosis (DVT) - the development of a clot in the lower legs - can prove deadly, since the clot can travel to the heart and lungs
-
Newer Blood Thinners Don't Raise Bleeding Risk
Risk is similar to warfarin, study reports
-
A Medical Upside to Being Short: Fewer Blood Clots
The taller you are, the higher your odds for blood clots in your veins, research suggests
-
Common Food Nutrient Tied to Risky Blood Clotting
Gut bacteria reacts to compound in eggs and meat to produce chemical that ups heart disease risk, study says
-
Stent Patients: Death Risk After Bleeding, Clots
Prolonged treatment to prevent clots may increase bleeding risk in some patients, researchers warn
-
Study: Bleeding Risk From Common Blood Thinners
Research looked specifically at bleeds inside the skull and near the brain
-
Drinking Peroxide “Cleanse” Leads to Blood Clots
So-called 'super water' carries big risks, doctors warn
-
Pradaxa May Beat Warfarin After Bleeding Episode
Research also shows that resuming any anticoagulant is still safer than stopping the drugs in these cases
-
These Medicines Often Send Americans to ERs
CDC cites blood thinners, antibiotics, diabetes drugs for nearly half of adverse drug-related events
-
Clots May Be the Cause of Fainting in Some Elderly
But doctors don't often suspect pulmonary embolism, researchers say
-
How Long Do Patients With Clots in the Lung Need Blood Thinners?
New French study suggests that anti-clotting drugs may be needed for the very long term
-
Time Spent in the OR May Be Linked to Blood Clots, Study Shows
Longer operations are associated with higher risk
-
Common Painkillers Tied to Blood Clot Risk, Study Suggests
NSAID medicines include aspirin, ibuprofen and naproxen/Aleve
-
Most Treatments for Blood Clots Appear Safe, Effective
Analysis of studies shows almost all strategies have similar outcomes, Canadian researchers report
-
Study: Aspirin Might Work Instead of Warfarin for Deep Vein Clots
But heart experts say it's not a preferred or ideal choice
-
FDA Approves New DVT Blood Clot Treatment
The FDA has approved the use of the anti-clotting drug apixaban (Eliquis) to treat deep vein thrombosis (DVT) and pulmonary embolism (PE.)
Pagination